Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
Stereotaxis (NYSE: STXS) will report its third quarter 2025 financial results on Tuesday, November 11, 2025 after the U.S. market close.
The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) the same day to discuss results and corporate developments. Participants may dial 800-715-9871 (US/Canada) or 646-307-1963 (international) using pass code 4402192. A live and replay webcast will be available via the company’s investor relations website, and a phone replay will be available for one month beginning about four hours after the call.
Stereotaxis (NYSE: STXS) riferirà i suoi risultati del terzo trimestre 2025 il martedì 11 novembre 2025 dopo la chiusura del mercato statunitense.
L'azienda ospiterà una call conference e webcast alle 16:30 ora ET (1:30 PM PT) lo stesso giorno per discutere i risultati e gli sviluppi societari. I partecipanti possono comporre lo 800-715-9871 (US/Canada) o lo 646-307-1963 (internazionale) usando il codice di accesso 4402192. Una diretta e una trasmissione in replay saranno disponibili sul sito di relazioni con investitori della società, e un replay telefonico sarà disponibile per un mese a partire circa quattro ore dopo la chiamata.
Stereotaxis (NYSE: STXS) reportará sus resultados del tercer trimestre de 2025 el martes 11 de noviembre de 2025 después del cierre del mercado estadounidense.
La compañía organizará una llamada de conferencia y webcast a las 4:30 p.m. hora del Este (1:30 p.m. hora del Pacífico) ese mismo día para discutir los resultados y desarrollos corporativos. Los participantes pueden marcar al 800-715-9871 (EE. UU./Canadá) o al 646-307-1963 (internacional) usando el código de acceso 4402192. Un webcast en vivo y de repetición estará disponible a través del sitio web de relaciones con inversores de la empresa, y una repetición telefónica estará disponible durante un mes aproximadamente cuatro horas después de la llamada.
Stereotaxis (NYSE: STXS)는 2025년 3분기 실적을 미국 시장 마감 후인 2025년 11월 11일 화요일에 발표합니다.
회사 측은 같은 날 컨퍼런스 콜 및 웹캐스트를 동부시간 16:30 (태평양 표준시 1:30 PM)에 개최해 실적 및 회사 개발 사항에 대해 논의합니다. 참가자들은 미국/캐나다 800-715-9871 또는 국제용 646-307-1963으로 접속 코드 4402192를 사용하여 참여할 수 있습니다. 생방송 및 재생 웹캐스트는 회사의 투자자 관계 웹사이트를 통해 이용 가능하며, 전화 재생은 통화 후 약 네 시간 후 시작해 한 달간 제공됩니다.
Stereotaxis (NYSE: STXS) divulguera ses résultats financiers du troisième trimestre 2025 le mardi 11 novembre 2025 après la clôture du marché américain.
La société organisera un appel conférences et webcast à 16 h 30, heure de l’Est (1 h 30, heure du Pacifique) le même jour pour discuter des résultats et des développements d’entreprise. Les participants peuvent composer le 800-715-9871 (États‑Unis/Canada) ou le 646-307-1963 (international) en utilisant le code d’accès 4402192. Un webcast en direct et en replay sera disponible via le site des relations investisseurs de la société, et une réémission téléphonique sera disponible pendant environ un mois après l’appel.
Stereotaxis (NYSE: STXS) wird seine Ergebnisse des dritten Quartals 2025 am Dienstag, dem 11. November 2025 nach Börsenschluss in den USA berichten.
Das Unternehmen wird am selben Tag eine Konferenzschaltung und Webcast um 16:30 Uhr ET (1:30 Uhr PT) durchführen, um Ergebnisse und Unternehmensentwicklungen zu besprechen. Die Teilnehmer können die Nummer 800-715-9871 (USA/Kanada) oder 646-307-1963 (international) verwenden und den Zugangscode 4402192 eingeben. Ein Live-Webcast und ein Replay-Webcast stehen über die Investor-Relations-Website des Unternehmens zur Verfügung, und ein telefonischer Replay wird etwa vier Stunden nach dem Anruf für einen Monat verfügbar sein.
Stereotaxis (NYSE: STXS) ستعلن عن نتائجها المالية للربع الثالث من 2025 في يوم الثلاثاء 11 نوفمبر 2025 بعد إغلاق السوق الأمريكية.
ستستضيف الشركة مكالمة مؤتمر وبثاً مباشراً في الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة (1:30 مساءً بتوقيت المحيط الهادئ) في اليوم نفسه لمناقشة النتائج والتطورات المؤسسية. يمكن للمشاركين الاتصال على الرقم 800-715-9871 (الولايات المتحدة/كندا) أو 646-307-1963 (دولياً) باستخدام رمز الدخول 4402192. سيكون هناك بث مباشر وبث لإعادة على موقع علاقات المستثمرين الخاص بالشركة، وسيتاح إعادة الاتصال الهاتفي لمدة شهر بدءاً من نحو أربع ساعات بعد المكالمة.
Stereotaxis (NYSE: STXS) 将在 2025 年第三季度 的财务业绩于 2025 年 11 月 11 日,星期二 美国市场收盘后公布。
公司将在同一天举行 电话会议和网络直播,时间为 美东时间 16:30(太平洋时间 1:30 PM),以讨论业绩和公司发展事项。参与者可以拨打 800-715-9871(美国/加拿大)或 646-307-1963(国际),使用接入码 4402192。现场视频与回放将通过公司的投资者关系网站提供,电话回放将在通话后大约四小时开始,持续一个月。
- None.
- None.
ST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2025 third quarter on Tuesday, November 11, 2025 at the close of the U.S. financial markets. The Company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the Company’s results and corporate developments.
What: | Stereotaxis third quarter 2025 financial results conference call |
When: | Tuesday, November 11, 2025, at 4:30 p.m. ET (1:30 p.m. PT) |
Dial In Number: | To access the live call, dial 800-715-9871 (US and Canada) or 646-307-1963 (International) and give the participant pass code 4402192. |
Webcast: | To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website at http://ir.stereotaxis.com/. |
Call Replay: | A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, please click here. |
About Stereotaxis
Stereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room. Stereotaxis technology has been used to treat over 150,000 patients across the United States, Europe, Asia, and elsewhere. For more information, please visit www.stereotaxis.com.
Investor Contacts:
David L. Fischel
Chairman and Chief Executive Officer
Kimberly Peery
Chief Financial Officer
314-678-6100
Investors@Stereotaxis.com
